Valuation: UCB

Market Cap 41.37B 47.63B 38.42B 35.43B 66.74B 4,547B 67.95B 455B 178B 2,259B 179B 175B 7,595B P/E 2026 *
23.6x
P/E 2027 * 18.5x
Enterprise Value 41.26B 47.5B 38.32B 35.34B 66.56B 4,535B 67.77B 454B 178B 2,252B 178B 174B 7,574B EV / Sales 2026 *
4.83x
EV / Sales 2027 * 4.07x
Free-Float
61.59%
Yield 2026 *
0.67%
Yield 2027 * 0.69%
1 day+2.86%
1 week-9.27%
Current month-14.81%
1 month-13.45%
3 months-2.32%
6 months-14.35%
Current year-6.45%
1 week 214
Extreme 214
251.5
1 month 214
Extreme 214
266.55
Current year 214
Extreme 214
289.5
1 year 181.15
Extreme 181.15
289.5
3 years 65.4
Extreme 65.4
289.5
5 years 65.4
Extreme 65.4
289.5
10 years 54.84
Extreme 54.84
289.5
Manager TitleAgeSince
Chief Executive Officer 67 2014-12-31
Director of Finance/CFO 59 2020-06-30
Chief Tech/Sci/R&D Officer 59 2024-04-30
Director TitleAgeSince
Director/Board Member 55 2011-12-31
Director/Board Member 67 2014-12-31
Director/Board Member 56 2014-04-23
Date Insider Type Main position Quantity % Market Cap.
1/15/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
1/15/26 Fiscal year

Executive/Senior Manager

3,000 0.0015%
1/15/26 Buy

Director

500 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+2.81%-9.27%+17.20%+177.20% 47.63B
+6.17%+13.26%+33.13%-1.04% 75.12B
+3.25%+52.70%+52.70%+52.70% 49.48B
-3.81%+6.32%-54.61%-54.17% 42.95B
-0.62%+3.64%+64.19%-21.60% 30.72B
-3.23%+5.40%+58.59%+94.94% 24.93B
+6.29%+1.58%+80.16%-51.19% 22.98B
-1.59%-3.61%-11.53%+150.58% 19.56B
+1.04%+4.33%+77.00%+131.65% 17.19B
-1.68%-0.95%+80.05%+138.64% 16.06B
Average +0.87%+2.90%+39.69%+61.77% 34.66B
Weighted average by Cap. +1.74%+3.86%+32.40%+47.90%

Financials

2026 *2027 *
Net sales 8.54B 9.84B 7.93B 7.32B 13.78B 939B 14.03B 93.92B 36.77B 466B 36.94B 36.13B 1,568B 9.63B 11.08B 8.94B 8.24B 15.53B 1,058B 15.81B 106B 41.43B 525B 41.61B 40.7B 1,767B
Net income 1.74B 2B 1.61B 1.49B 2.8B 191B 2.85B 19.1B 7.48B 94.85B 7.51B 7.35B 319B 2.27B 2.61B 2.11B 1.94B 3.66B 249B 3.73B 24.94B 9.77B 124B 9.81B 9.59B 417B
Net Debt -113M -131M -105M -97.15M -183M -12.47B -186M -1.25B -488M -6.19B -490M -480M -20.82B -2.21B -2.55B -2.06B -1.9B -3.57B -243B -3.64B -24.34B -9.53B -121B -9.57B -9.36B -406B
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
9,765
Date Price Change Volume
26-07-31 224.40 +3.41% 92,553
26-07-30 €217.00 -13.51% 857,389
26-07-29 €250.90 +0.28% 171,258
26-07-28 €250.20 +1.79% 227,096
26-07-27 €245.80 -0.08% 136,709
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
217.00EUR
Average target price
287.95EUR
Spread / Average Target
+32.69%

Quarterly revenue - Rate of surprise